<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2010</study_start_year><data_sharing_plan>IPD Sharing (as of September 2017): No</data_sharing_plan><condition>Adenomatous Polyposis Coli</condition><condition>Colorectal Neoplasms</condition><condition>Familial Adenomatous Polyposis</condition><condition>Nasopharyngeal Neoplasms</condition><disease>Adenomatous Polyposis Coli</disease><disease>Colorectal Neoplasms</disease><disease>Familial Adenomatous Polyposis</disease><disease>Nasopharyngeal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2052587</full_dataset_link><location>Puerto Rico</location><location>United States</location><study_start_month>10</study_start_month><keyword>Curcumin</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Curcumin in Treating Patients With Familial Adenomatous Polyposis</name><description>This randomized phase II trial studies curcumin in treating patients with familial adenomatous polyposis. Curcumin may prevent colorectal cancer in patients with a history of rectal polyps or colorectal neoplasia.</description><dates><creation>2010-10-15</creation></dates><accession>2052587</accession><cross_references><ClinicalTrials___gov>NCT00641147</ClinicalTrials___gov></cross_references></HashMap>